Study Suggests Diet High in Saturated Fat Contributes to Prostate Cancer Treatment Failure

In the online version of the International Journal of Cancer, Dr. Sara Strom and associates evaluate the association between saturated fat intake and biochemical failure among men who underwent radical prostatectomy (RP).

A cohort of 390 patients who underwent radical prostatectomy at MD Anderson Cancer Center had a semi-quantitative validated Block food frequency questionnaire modified to their regional diets and completed for the year prior to the diagnosis of prostate cancer. Body mass index (BMI) was also calculated. Clinical and pathological data were abstracted from medical records. Categorical and continual variables were analyzed.

Men who consumed high saturated fat diets (HSF) were younger and had higher BMIs at diagnosis than men with who consumed low saturated fat diets (LSF). There were no statistically significant differences in clinico-pathologic characteristics, family history of prostate cancer, education, history of diabetes or physical activity between the 2 groups. Men on HSF diets also consumed more total calories that men on LSF diets. Saturated fats were most commonly consumed as beef steaks, cheese and cheese spreads, hamburgers and cheeseburgers, eggs, ice cream and salad dressings.

During the mean 97 month follow-up period, 20% of patients with organ-confined prostate cancer experienced a PSA failure. Patients on a HSF diets were significantly more likely to have a PSA failure and had significantly shorter PSA-failure free survival than men on a LSF diet (26.6 vs. 44.7 months, respectively). At 5 years post radical prostatectomy, 65% of patients who consumed HSF diets had no evidence of prostate cancer compared to 80% of men who ate a LSF diet. Men who were both obese and ate a HSF diets had the shortest biochemical failure-free survival (19 months) and non-obese men on a LSF diet had the longest (46 months). The data from the model were not altered by the inclusion of amount of physical activity performed by the subjects.

Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS

Source: UroToday

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

New biomarkers may influence drug design and alternative treatments of cancer, study shows   Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy   Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy   New drug for neuroblastoma shows promise in phase I study   Experimental treatment sends deadly leukemia into remission   Study could reduce unnecessary cancer screening   UA researchers discover component of cinnamon prevents colorectal cancer in mice   Profiling approach to enable right lung cancer treatment match   Fat grafting technique improves results of breast augmentation   Germline TP53 mutations in patients with early-onset colorectal cancer   Clinical trial suggests combination therapy is best for low-grade brain tumors   UW research shows sensor technology may help improve accuracy of clinical breast exams